• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

14 Centers to Use IBM Watson for Cancer Genetics

by HITC Staff 05/08/2015 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

IBM's Dr. Watson Is NOT A Meaningful User

Fourteen US and Canadian cancer centers announced it will used IBM Watson to compare a patient’s tumor genetic fingerprints to databases of cancer genes and findings of scientific papers and clinical trials on cancer in a matter of minutes, BI reports. Oncology is the first specialty where matching therapy to DNA has improved patient outcomes and has inspired President Obama’s “Precision Medicine Initiative” announced in January.

Typically, drugs targeting cancer-causing mutations can takes weeks to identify. By utilizing IBM Watson’s cloud-based platform, DNA sequencing can be performed in a matter of minutes.

Faced with such a data deluge, “the solution is going to be Watson or something like it,” said oncologist Norman Sharpless of the University of North Carolina Lineberger Cancer Center. “Humans alone can’t do it.”.

How It Works

Oncologists will upload the DNA fingerprint of a patient’s tumor, which indicates which genes are mutated and possibly driving the malignancy. Watson will then look for actionable targets, matching them to approved and experimental cancer drugs and even non-cancer drugs (if Watson decides the latter interface with a biological pathway driving a malignancy). The centers will pay a subscription fee for Watson, which IBM did not disclose.

Watson Drawbacks

For now it is still unclear if this “big data” approach will help patients; however, scientists are hopeful this approach can make a difference in cancer treatment. Steve Harvey, vice president of IBM Watson Health admits that Watson does have trouble identifying actionable targets in cancers with many mutations. In most common tumors, traditional chemotherapy and radiation remains the standard of care. Therefore, genetic sequencing/analysis may not make a difference. IBM spent more than a year developing a scoring system so Watson can do that, since targeting non-driver mutations would not help.

“Traditional cancer treatments are moderately effective, associated with moderate toxicity, and many patients still succumb to the disease. There’s been a lot of pessimism among those [fighting] cancer, and Watson offers an opportunity to fight back against that pessimism,” said Lukas Wartman, assistant director of Cancer Genomics at Washington University and a leukemia survivor, at Tuesday’s press conference

The fourteen participating healthcare centers include:

  1. Ann & Robert H Lurie Children’s Hospital of Chicago
  2. BC Cancer Agency
  3. City of Hope
  4. Cleveland Clinic
  5. Duke Cancer Institute
  6. Fred & Pamela Buffett Cancer Center in Omaha, Nebraska
  7. McDonnell Genome Institute at Washington University in St. Louis
  8. New York Genome Center
  9. Sanford Health
  10. University of Kansas Cancer Center
  11. University of North Carolina Lineberger Cancer Center
  12. University of Southern California Center for Applied Molecular Medicine ;
  13. University of Washington Medical Center
  14. Yale Cancer Center
  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: IBM Watson

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Digital Health Funding Q3 2025: Choppy Undercurrents Beneath a Steady Surface

Featured Interview

ConcertAI VP Shares View on AI Hallucinations and the Fabricated Data Crisis in Scientific Publishing

Most-Read

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

KLAS Report: Epic's Native Ambient Speech Tool Reshapes Customer AI Strategies

KLAS Report: Epic’s Native Ambient Speech Tool Reshapes Customer AI Strategies

Epic Unveils MyChart Central and New APIs to Advance Interoperability at Open@Epic

Epic Outlines Roadmap for Next-Generation Data Sharing at Open@Epic

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

Oracle Confirms Layoffs in Kansas City

Oracle Confirms Layoffs in Kansas City

Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis

Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis

Optain Health Secures $26M to Advance AI-Powered Retinal Screening

Optain Health Secures $26M for AI-Powered Retinal Screening

Sutter Health and Epic Launch "Sutter Sync" to Optimize Remote Chronic Care

Sutter Health and Epic Launch “Sutter Sync” to Optimize Remote Chronic Care

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |